Aquestive Therapeutics, Inc. AQST Interest Paid
Interest Paid at other companies
Other financials
Where this comes from
Reported directly by Aquestive Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InterestPaidNet.
The official record: Aquestive Therapeutics, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Aquestive Therapeutics, Inc.'s interest paid.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Aquestive Therapeutics, Inc.'s interest paid?
- Aquestive Therapeutics, Inc. (AQST) reported interest paid of $1.52M in Q1 2026.
- How has Aquestive Therapeutics, Inc.'s interest paid changed year-over-year?
- Aquestive Therapeutics, Inc.'s interest paid decreased by 0.1% year-over-year, from $1.53M to $1.52M.
- What is the long-term trend for Aquestive Therapeutics, Inc.'s interest paid?
- Over 4 years (2021 to 2025), Aquestive Therapeutics, Inc.'s interest paid has grown at a -1.3% compound annual growth rate (CAGR), from $6.44M to $6.1M.
- What does interest paid mean?
- Supplemental disclosure of total cash interest paid on all debt and lease obligations during the period.